Offer - Urjas Oil for just ₹ 1 X
Fulvenat is a prescription medicine that is available as a Injection. Breast Cancer are some of its major therapeutic uses.
The correct dosage of Fulvenat depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Fulvenat include Urinary tract infection, Flu-like Symptoms. Besides the aforementioned side effects, there are other adverse effects of Fulvenat as well, which are listed below. Usually, these side effects of Fulvenat go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Fulvenat's effect is Severe during pregnancy and Moderate for lactating mothers. In addition, Fulvenat's effects on the liver, heart and kidney are discussed below in the Fulvenat related warnings section.
Fulvenat can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Fulvenat in conditions like Thrombocytopenia and ITP. Other contraindications of Fulvenat have been discussed in the sections ahead.
Drug reaction of Fulvenat with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Fulvenat is not safe while driving, and is is not addictive in nature.
Fulvenat is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Geriatric |
|
Is the use of Fulvenat safe for pregnant women?
Fulvenat shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Fulvenat safe during breastfeeding?
Fulvenat may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Fulvenat, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Fulvenat.
What is the effect of Fulvenat on the Kidneys?
Fulvenat has very mild side effects on the kidneys.
What is the effect of Fulvenat on the Liver?
Fulvenat can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Fulvenat on the Heart?
Side effects of Fulvenat rarely affect the heart.
Fulvenat should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Fulvenat unless your doctor advises you to do so -
Is this Fulvenat habit forming or addictive?
No, there is no any evidence that Fulvenat is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Fulvenat. So it is best to avoid driving.
Is it safe?
Fulvenat is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Fulvenat cannot treat any kind of mental disorder.
Interaction between Food and Fulvenat
Due to a lack of research, nothing can be said about the consequences of taking Fulvenat together with food.
Interaction between Alcohol and Fulvenat
It is difficult to say anything about the effect of Fulvenat and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Faslodex® (fulvestrant)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 313